by admin | Feb 22, 2024 | News & Opinions
By Joseph Keenan – Fierce Pharma – Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process. The two companies will integrate Multiply Lab’s...
by admin | Feb 21, 2024 | News & Opinions
By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...
by admin | Feb 20, 2024 | News & Opinions
By Andrea Park -Fierce Biotech – For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial...
by admin | Feb 16, 2024 | News & Opinions
by Technology Networks – Biopharma News – Initial trial suggests invariant natural killer cell therapy improves survival. Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with...
by admin | Feb 15, 2024 | News & Opinions
By Dr Naomi Phillips – Progress.org – Viral genetic material, integrated into our DNA millions of years ago, has an essential role in a key early stage in embryo development. Using a mouse model, scientists in Spain have shown that endogenous retroviruses,...
